MGC Pharmaceuticals
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Central Working Ecclestone Yards 25 Eccl...Website
www.mgcpharma.co.ukRevenue
<$5 MillionIndustry
About MGC Pharmaceuticals
MGC Pharmaceuticals Org Chart
Is MGC Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on MGC Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if MGC Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at MGC Pharmaceuticals
Funding: Get notified immidiatlly once MGC Pharmaceuticals has new funding data
MGC Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if MGC Pharmaceuticals is spiking on competitors!
Check if MGC Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when MGC Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined MGC Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
MGC Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MGC Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MGC Pharmaceuticals.
MGC Pharmaceuticals financials insights
Gather financial insights about MGC Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$10M
Other Financing Round
$2.2M
MGC Pharmaceuticals Tech Stack
A closer look at the technologies used by MGC Pharmaceuticals
Most Recent Scoops
MGC Pharmaceuticals News & Media
MGC Pharmaceuticals secures funding as epilepsy treatment made available in the UK
The plant-derived drug developer has raised c.£1.2 million in a conditional placing, alongside securing c.£0.63 million in funding for the CannEpil clinical trial and the launch of a UK broker option share offer to raise up to £0.75 million. In a separate statement, the company announced that their proprietary product, CannEpil®, is now available by Named Patient Request in the UK.MGC Pharma's CannEpil® Now Accessible to UK Patients on Named Patient Request Basis
European pharmaceutical company offers its investigational medicinal product to a wide range of specialist medical practitioners in the United Kingdom Epidiolex's Success Highlights Potential for MGC Pharma's CannEpil® The recent success of Epidiolex, a CBD-based epilepsy treatment that...IN BRIEF: MGC Pharma receives AUD800,000 funding from Mercer Street - Morningstar
MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures AUD800,000 ...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MGC Pharmaceuticals
MGC Pharmaceuticals Limited, founded in 2005, operates as a biopharma company at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global biopharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted glo... Read More